C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992

Circulation

Volumn 99, Issue 2, 1999, Pages 237-242

  Koenig, Wolfgang ^a   Sund, Malte ^b   Fröhlich, Margit ^a   Fischer, Hans Günther ^a   Löwel, Hannelore ^c   Döring, Angela ^c   Hutchinson, Winston L ^d   Pepys, Mark B ^d  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Institute of Epidemiology   (Germany)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Coronary disease; Epidemiology; Incidence; Proteins

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY RISK; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; SMOKING HABIT;

EID: 0032923669     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.2.237     Document Type: Article

References (55)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:802-809.
2. Van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
3. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA. 1987;257:2318-2324.
4. Ernst E, Koenig W. Fibrinogen and cardiovascular risk. Vascular Med. 1997;2:115-125.
5. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 1996;94: 2057-2063.
6. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
7. Dinerman JL, Mehta JL, Saldeen TGP, Eerson S, Wallin R, Davda R, Davidson A. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol. 1990;15: 1559-1563.
8. Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med. 1987;317:1361-1365.
9. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol. 1990;65:168-172.
10. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331: 417-424.
11. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol. 1984;53:13-23.
12. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Int Med. 1989;225:293-296.
13. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 1996;348:567-572.
14. Pepys MB. The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine. 2nd ed. Oxford, UK: Oxford University Press; 1995: 1527-1533.
15. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993;91:1351-1357.
16. WHO Expert Committee on Biological Standardization. WHO Technical Report Series 760. Geneva, Switzerland; 1987.
17. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem. 1997;43:52-58.
18. Wilkins J, Gallimore JR, Moore E, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem. 1998; 44:1358-1361.
19. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
20. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT Research Group. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537-547.
21. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
22. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121-1127.
23. WHO-MONICA-Project Principal Investigators. The World Health Organization Monica Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol. 1988;41:105-114.
24. WHO MONICA Project. WHO MONICA project: objectives and design. Int J Epidemiol. 1989;18(suppl 1):29-37.
25. Keil U, Stieber J, Döring A, Chambless L, Härtel U, Filipiak B, Hense HW, Tietze M, Gostomzyk JG. The cardiovascular risk factor profile in the study area Augsburg: results from the first MONICA survey 1984/1985. Acta Med Scand. 1988;728(suppl):119-128.
26. Keil U, Cairns V, Döring A, Härtel U, Jorcik J, Perz S, Stieber J. MONICA-Project Region Augsburg. Manual of Operations, Survey. München, Germany: Gesellschaft für Strahlen und Umweltforschung; 1985. GSF report 20/85.
27. World Health Organization. MONICA Manual: CVD/MNC. Geneva, Switzerland: WHO; 1990.
28. Bray GA. Definition, measurement and classification of the syndromes of obesity. Int J Obesitiy. 1978;2:99-112.
29. Koenig W, Sund M, Döring A, Ernst E. Leisure-time physical activity but not work-related physical activity is associated with decreased plasma viscosity: results from a large population sample. Circulation. 1997;95: 335-341.
30. Löwel H, Lewis M, Hörmann A, Keil U. Case finding, data quality aspects and comparability of myocardial infarction registers: results of a south German register study. J Clin Epidemiol. 1991;44:249-260.
31. WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
32. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, Mass; Wright; 1982.
33. Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc. 1972;34 (seriesB):187-220.
34. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340-349.
35. SAS/STAT Software: Changes and Enhancements for Release 6.12. Cary, NC: SAS Institute Inc; 1996.
36. S-PLUS User's Guide, Version 4.0. Seattle, Wass: MathSoft Inc; 1997.
37. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study. BMJ. 312;1996:1061-1065.
38. Baumann H, Gauldie J. The acute phase response. Immunol Today. 1994;25:74-80.
39. Dong Q, Wright JR. Expression of C-reactive protein by alveolar macrophages. J Immunol. 1995;156:4815-4820.
40. Murphy TM, Baum LL, Beaman KD. Extrahepatic transcription of human C-reactive protein. J Exp Med. 1991;173:495-498.
41. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430-436.
42. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol. 1996;67:1123-1137.
43. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481-494.
44. Volanakis JE, Narkates AJ. Interaction of C-reactive protein with artificial phosphatidyl-choline bilayers and complement. J Immunol. 1981; 126:1820-1825.
45. Li YP, Mold C, Du Clos TW. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes. J Immunol. 1994; 152:2995-3005.
46. Pepys MB, Rowe IF, Baltz ML. C-reactive protein: binding to lipids and lipoproteins. Int Rev Exp Pathol. 1985;27:83-111.
47. Volanakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci. 1982;389:235-250.
48. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513-520.
49. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernández-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenecity of human atherosclerotic plaques. Circulation. 1997;95:594-599.
50. Kaikita K, Ogawa H, Yasue H, Takeya M, Takahashi K, Saito T, Hayasaki K, Horiuchi K, Takizawa A, Kamikubo Y, Nakamura S. Tissue factor expression on macrophages in coronary plaques in patients with unstable angina. Arterioscler Thromb Vasc Biol. 1997;17:2232-2237.
51. Ardissino D, Merlini PA, Ariens R, Coppola R, Bramucci E, Mannucci PM. Tissue factor antigen and activity in human coronary atherosclerotic plaques. Lancet. 1997;349:769-771.
52. Rowe IF, Walker LN, Bowyer DE, Soutar AK, Smith LC, Pepys MB. Immunohistochemical studies of C-reactive protein and apolipoprotein B in inflammatory and arterial lesions. J Pathol. 1985;145:241-249.
53. Hatanaka K, Li X-A Masuda K, Yutoni C, Yamamoto A. Immunohistochemical localization of C-reactive protein binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method. Pathol Int. 1995;45:635-641.
54. Torzewski J, Torzewski M, Boyer DE, Fröhlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998;18:1386-1392.
55. Fiedel BA, Simpson RM, Gewurz H. Effects of C-reactive protein (CRP) on platelet function. Ann N Y Acad Sci. 1982;263-273.